Alginic Acid

§4.1 of the fetched product, verbatim: 'Treatment of symptoms resulting from the reflux of acid, bile and pepsin into the oesophagus such as acid regurgitation, heartburn, indigestion (occurring due to the reflux of stomach contents) … accompanying reflux oesophagitis, including symptoms of laryngopharyngeal reflux…'. §4.2, verbatim: 'Adults and children 12 years and over: 5-10ml after meals and at bedtime. Children under 12 years: Should be given only on medical advice. Elderly: No dose modification is required for this age group. Hepatic Impairment: No dose modification necessary. Renal Insufficiency: Caution if highly restricted salt diet is necessary (see section 4.4).' Both numbers in the dose line are printed there. || NO MAXIMUM DOSE IS PUBLISHED, AND THAT IS DELIBERATE. §4.2 prints no ceiling. §4.4 refers to 'The maximum daily dose of this product' but expresses it only as a percentage of the WHO recommended maximum sodium intake ('equivalent to 23.14 % …'), never as millilitres or doses — converting that percentage into a volume would be arithmetic on the label, not a figure the label prints, so maxDose is left unset. The top of the 5-10 ml band is a per-dose range, not a stated maximum, and is not promoted into maxDose either. || SUBSTANCE-NAME CAVEAT, FOR A CONTENT DECISION RATHER THAN A RE-FETCH: this page is titled 'Alginic Acid' but categorised as an alginate/antacid class page, and the fetched product is a raft-forming alginate supplied under that class and named in the page's own brandNames. The bundle contains no §1/§2 composition section, so nothing in it evidences the precise alginate salt; the site's own clinical pearls describe Gaviscon Advance as 'alginate + potassium bicarbonate'. The dose is therefore published PRODUCT-SCOPED — the product is named inside the dose text — and must not be read as a figure for alginic acid as a bare substance or for any other alginate. If the page is meant to carry alginic acid as a distinct named substance, the page should be renamed/split rather than this source replaced. || ELDERLY: §4.2, verbatim: 'No dose modification is required for this age group.' HEPATIC: 'No dose modification necessary.' RENAL: 'Caution if highly restricted salt diet is necessary' — see the sodium and potassium entries under monitoring.

NO PAEDIATRIC NUMBER IS PUBLISHED because the label prints none: §4.2 covers 'Adults and children 12 years and over' with 5-10 ml and refers everyone under 12 to medical advice. Gaviscon Infant — this page's other listed brand, and the whole of its infant/regurgitation use — is a SEPARATE product with different constituents and its own sachet-based dosing, and no part of it appears in this bundle; the adult 5-10 ml volume must never be applied to it. Confirm any dose for a child under 12 against a children's formulary.